CytomX Therapeutics (CTMX) Files $250M Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- US stock futures little changed as strong quarter nears end
- Strong dollar pushes yen to 40-year low as traders test Japanese authorities
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
Form S-3 CytomX Therapeutics,
August 9, 2024 4:07 PM EDTTable of Contents
As filed with the Securities and Exchange Commission on August 9, 2024
Registration No. 333-
... More
